Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion
Clinical trial NCT06029998 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06029998
- Sponsor
- University of Utah
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-11
- Primary completion
- 2026-12-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.